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IDIOTYPE-ANTI-IDIOTYPE  NETWORK 
II.  Activation of Silent Clones by Treatment 
at Birth with Idiotypes Is Associated with the Expansion 
of Idiotype-specific Helper T  Cells* 
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From the Department  of Microbiology, Mount Sinai School of Medicine,  New  York 10029; and the 
Shanghai  Institute of Cell Biology, Shanghai,  People's Republic of China 
The immune system has been envisaged as a  web of variable region  domains  in 
which the connection between clones is based on fragile idiotype links (1). The delicate 
balance that is established between clones as well as the various subsets of cells that 
regulate  their expression can be easily upset by the influence of antigen,  idiotypes, 
and anti-idiotypes (2). 
We have studied  the consequences of perturbing the immune network formed by 
the clones that comprise the bacterial levan  (BL) 1 idiotype (Id) system. This system 
displays  certain  characteristics  that  render  it  particularly  suitable  for  studies  of 
regulation  of the immune response:  first, immunization with BL, which  is a  fl2---~6 
polyfructosan  with  f12--*l  branch  points,  leads  to  a  vigorous  T  cell-independent 
antibody response in  adult  mice. This response  in  IghC" mice is  composed of two 
distinct families of antibodies: the first binds to fl2----~6 fructosan, whereas the second 
binds to fl2---6 as well as f12----~l epitopes.  This latter group expresses the  EPC109 
(El09) dominant cross-reactive idiotype (IdX), E 109IdX, shared with inulin-binding 
myeloma proteins (3).  Second, there is a substantial ontogenic delay in the activation 
of genes that encode for E 109IdX fl2---~6 and f12----~  1 fructosan response. However, the 
fl2---~6 fructosan-reactive clones can be expanded at birth and their expression can be 
studied  independently of the anti-fl2---~ 1 fructosan-reactive clones in  1-mo-old mice 
(4). Third, antibodies bearing the idiotopes expressed on APBC48 (A48) and UPC 10 
(U10), two independent fl2--~6 fruetosan-binding myeloma proteins, cannot be iden- 
tified in the sera of BL-immune mice, suggesting that A48Id or U 10Id are markers of 
silent clones (3). 
In previous studies we have shown that A48Id silent clones can be activated by an 
anti-idiotype induced perturbation of the steady state network in three experimental 
conditions as follows: (a) an alteration in the balance of E 109IdX dominant clones vs. 
* Supported by grant PCN1105788 from the National Science Foundation and by grant IC-275 from 
the American Cancer Society, Inc. 
1 Abbreviations used in this paper: A48, ABPC48; BL, bacterial levan; BSA, bovine serum albumin; DNP, 
dinitrophenyl; El09, EPC 109; ELISA,  enzyme-linked  immunosorbent assay; HA, hemagglutination assay; 
HI, hemagglutination-inhibition assay; Id, idiotype; IdX, cross-reactive  idiotype; In, inulin; In-BA, In- 
Brucetla abortus; KLH, keyhole  limpet hemocyanin; M384, MOPC384; M460, MOPC460; NP, (4-hydroxy- 
3-nitrophenyl)acetyl; PFC, plaque-forming  cell; RIA, radioimmunoassay;  SRBC, sheep erythrocytes; TNP, 
trinitrophenyl; UI0, UPC10. 
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A48Id  ÷ clones was achieved in nude mice after the administration of anti-E109IdX 
antibodies.  This treatment  led  to  the  appearance  of A48Id  +  anti-fl2---*6  fructosan 
antibodies  (5);  (b)  mice were injected at birth with minute amounts of anti-A48Id 
antibodies. About 40% of the anti-BL antibodies produced in these animals bore the 
A48Id (6); (c) silent clones were activated in adult mice hyperimmunized with anti- 
A48Id  antibodies  in  Freund's  complete adjuvant.  These animals,  which  produced 
anti-(anti-A48Id)  antibodies,  developed  substantial  A48Id  +  anti-BL  antibodies  in 
response to immunization with BL (7). 
In this paper, we present  results that  demonstrate the activation of A48Id silent 
clones by the administration at birth of minute amounts of immunoglobulin bearing 
the A48 idiotype. This activation is associated with the expansion of A48Id-specific 
helper T  cells, which presumably function in the fine tuning of the expression of the 
bacterial levan idiotype repertoire. 
Materials and Methods 
Animals.  Normal and nu/nu BALB/c mice, 8-12 wk old, were purchased from the Charles 
River  Breeding Laboratory,  Wilmington, MA.  1-d-old  BALB/c  mice were  obtained from 
breeding in our colony at the Mount Sinai School of Medicine, New York. 
Antigens.  BL from Aerobacter laevenicum was prepared according to a  previously described 
technique (3). Trinitrophenyl (TNP)-aminoethylearbamylmethyl-Ficoll  (TNP-FicolI) was pre- 
pared  as  described  previously  (8). Inulin (In)  obtained  from  Calbiochem-Behring Corp., 
American Hoeehst Corp., La Jolla, CA, was coupled to BruceUa abortus (In-BA) according to a 
described method (8). TNPls-BSA, TNP14-A48,and TNPa4-M384 were labeled according to 
the method described by Bikoff (9). 
Myeloma  Proteins and  Monoclonal Antibodies.  The  properties  of all  myeloma proteins and 
monoclonal antibodies used in this study are presented in Table I. 
Preparation of Anti-Idiotype  Antibody.  Syngeneic BALB/c anti-A48Id and anti-MOPC460Id 
(M460Id) antibodies were prepared by immunization  with monoclonal protein-keyhole limpet 
hemocyanin (KLH) conjugates. Antibodies were purified on Sepharose 4B Id columns. Cou- 
pling of antibodies to KLH and immunization schedules are as previously described (10). 
Labeling of Sheep Erythrocytes (SRBC) with BL, In, and TNP.  0-stearoyl derivatives of BL and 
In were prepared according to the method of H~immerling and Westphal (11) and were used 
to  coat  SRBC  as  previously described  (3). TNP-SRBC  were  prepared  by  the  method  of 
Rittenberg and Pratt (12). SRBC were coated with myeloma proteins by the chromic chloride 
method of using a concentration of 1 mg/ml of the appropriate protein (3). 
125  Labeling of Antibodies.  A48 monoclonal protein was labeled with  I by the chloramine T 
method (13). M460 and A48 myeloma protein was tritiated according to the method of Wilder 
TABLE  I 
Antibodies Used in This Study 
Designation  Antigen specificity  Bearing idiotype  Class 
ABPC48*  fl2---~6  A48  IgAk 
W3082"  f12---~  1  IdX A, B  IgAk 
UPC 10*  fl2---~6  U 10  IgG~  k 
76BL  (Aha)  36  fl2--~6  A48  IgM 
76BL(Aba)  42  fl2-~6  A48  IgM 
MPOC460*  DNP  M460  IgAk 
MOPC384*  Salmonella tranaroa lipopolysaccharide  M384  IgAk 
CD5.3  M460Id  Undefined  IgGab  k 
LPC 1  Unknown  Unknown  IgG2a  k 
* These myeloma proteins were a kind gift of Dr. Michael Potter, National Cancer Institute, National 
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et al. (14), and affinity-purified  anti-A48Id was labeled with alkaline phosphatase by a method 
previously described  (15). I~SI-goat anti-mouse was  obtained  from  New  England Nuclear 
(Boston, MA). 
Determination of Antibody Titers.  Hemagglutination assay (HA)  titers of antibody specific for 
/~2---,6, /~2---~1, and  TNP  were  determined  in  microtiter  plates  using SRBC  coated  with 
0-stearoyl  BL, 0-stearoyl  In, and TNP, respectively.  The titer recorded is logs of the highest 
dilution of antisera giving agglutination. 
Radioimmunoassay (RIA).  The anti-/~2---*6,  anti-/~2----~  1, and anti-TNP titers were determined 
by an RIA on microtiter plates coated with BL (50 #g/ml), In-bovine serum albumin (BSA) 
(30 btg/ml) or TNP-BSA (30/xg/ml), respectively, by incubating  on the plates for 18 h at 4°C. 
This was followed  by three washings and then the plates were incubated with 50% fetal calf 
serum for  1 h at 4°C. Plates were washed again three times with saline and incubated for 3 h 
at  4°C  with various dilutions of sera  from  immunized animals. After an additional three 
washings, the plates were reincubated with lrSI-goat anti-mouse (50,000 epm/50 #1) for 3 h at 
4°C. Radioactivity was measured in a gamma counter after extensive washing. The concentra- 
tion of anti-/32---~6,/32---~  1 fructosan, and anti-TNP antibodies in the sera of immunized animals 
was  determined from, the  linear part  of a  standard inhibition curve obtained with known 
amounts of unlabeled UPC10  (IgG2a), W3082  (IgA),  and  IgM  anti-dinitrophenyl (DNP) 
monoelonal antibody (Fig.  1). The amount of/~2--*1  fructosan antibodies obtained from the 
standard curve can be over-estimated because of the low binding affinity of W3082 myeloma 
protein, which is an IgA. 
Determination of Idiotype.  A hemagglutination-inhibition  assay (HI), described previously (2), 
was used to test sera for the presence of antibodies bearing either A48Id or M460Id. The titer 
recorded is given as logs of the highest dilution of sera giving inhibition. The RIA serum level 
of A48Id was determined by using microtiter plates coated with affinity-purified anti-A48Id 
antibodies (50 #g/ml) and 12SI-A48  as ligand. The precise concentration of antibody expressing 
A48Id was determined from a standard inhibition  curve obtained with A48 monoclonal protein. 
The serum level of antibodies bearing the M460Id was determined by using microtiter plates 
coated  with CD5.3  monoclonal antibody (3 /~g/ml)  and  [all]M460 as  ligand. The precise 
concentration of M460Id-bearing molecules was determined from a standard inhibition curve 
obtained with unlabeled M460. This method was described in detail elsewhere (7, 10). 
Determination of Shared A 48 Idiotypes by Enzyme-linked Immunosorbent Assay (ELISA).  Microtiter 
plates  (Dynatech  Cap.,  Alexandria,  VA)  were  coated  for  18  h  at  4°C  with  A48,  U10, 
76BL(AB~)36, or 76BL(ABs)42 (50/~g/ml) followed by three washings with phosphate-buffered 
saline. The plates were  then  incubated for  3  h  at  4°C  with alkaline phosphatase-labeled, 
affinity-purified  syngeneic anti-A48Id antibodies (5/~g/50 ~1) to establish the extent of binding 
of the anti-A48Id antibodies to individual monoclonal antibodies. To confirm the sharing of 
idiotypes, the alkaline phosphatase-labeled anti-A48Id antibodies were preabsorbed for 30 min 
at 23°C with equal amounts of purified A48, U10, 76BL(AB3)36, or 76BL(AB3)42 monoelonal 
antibodies. After extensive washing, the plates were incubated with substrate for  1 h at 37°C, 
and the reaction was measured at 405nm on a microelisa spectrophotometer. 
Detection of Plaque-forming Cells (PFC).  The number of cells secreting antibody specific  for 
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BL or TNP was determined by a modification of the Jerne plaquing technique as previously 
described (10). Briefly, 50 #1 of a suspension of immune spleen cells was added to 0.4 ml of 0.5% 
agaroset'that contained  0.1  ml  of sensitized erythrocytes (10%).  The  slides were  incubated 
initially for 2 h at 37°C and then they were reincubated for an additional hour in the presence 
of guinea pig complement (1:20). Control slides were prepared using a  mixture of the same 
immune spleen cells and unsensitized SRBC. Anti-BL PFC carrying the A48Id were enumerated 
by incorporating BALB/c anti-A48 antiserum into the agarose at a final concentration of 1  : 100 
and scoring the difference in the number of PFC obtained in the presence and absence of the 
inhibitor  (anti-A48).  Similarly, the  number  of anti-TNP  PFC  expressing the  M460Id  was 
determined by the addition to the agarose of BALB/c anti-M460 antiserum (1:500)  as inhibitor. 
Purification of T and B  Cells.  Splenic T  lymphocytes were purified by passage over nylon 
wool columns.  Purified splenic B  lymphocytes were  obtained  from  BALB/c  mice  injected 
intraperitoneally with 0.4 ml rabbit anti-mouse thymoeyte serum (M.A. Bioproducts, Walkers- 
ville, MD) that were killed 2 d later. The splenic lymphocytes were harvested and treated with 
anti-Thy-l.2 plus complement to remove any residual T  cells. 
Results 
Occurrence of A 48Id-bearing Immunoglobulins in BALB/c Mice  Treated at Birth  with A 48 
Monoclonal Protein.  We are extending our previous observation, which  showed  that 
A48Id silent clones can be activated by injection of anti-A48 antibodies, by studying 
the effect of the administration of BL and A48 monoclonal protein on the expression 
of these clones at birth. Injection of 10 #g of A48 monoclonal protein at birth, followed 
1  mo  later  by  immunization  with  BL,  led  to  the  appearance  of A48Id-bearing 
molecules in the serum of these mice, whereas injection of 10 #g of BL alone did not 
activate  the  A48Id  response.  The  appearance  of A48Id  +  molecules  in  the  serum 
required antigenic stimulation, because mice treated at birth only with A48 mono- 
clonal protein--but  not  immunized  with  BL--do  not  show  significant increases in 
the levels of anti-BL antibodies and A48Id-bearing molecules (Table II). These results 
indicated that administration of A48 monoclonal protein at birth led to the activation 
of clones expressing the A48Id; this activation requires antigenic stimulation. 
Occurrence of A48Id Molecules  Was Not Related to Persistence of A48 Monoclonal Protein 
Injected at Birth.  The  presence of A48Id-bearing immunoglobulins  in  the serum  of 
mice treated at birth with A48 monoclonal protein can originate in principle from the 
persistence of protein injected at birth. To investigate this possibility, we injected mice 
with  13  X  106 cpm  of [aH]A48 and studied the clearance of radioactivity from  the 
serum for 34 d  by collecting blood samples at various intervals. As can be seen in Fig. 
2, the amount of radioactivity measured at 34 d  would correspond to <8  ×  10 -4 #g 
TABLE  II 
Presence of Serum Antibodies Specific  for BL 
Immuni-  Number  Titer log2 units 
Treatment at birth  zation 1  of mice 
mo later  studied  HA (BL)  HI (A48Id) 
Nil  Nil  6  1.5 :l: 0.8  0.0 =k 0.0 
Nil  BL  2  5.5 + 0.5  0.5 + 0.5 
10/.tg BL  BL  3  5.0 + 0.6  0.0 :::l=  0.0 
10 #g A48  Nil  5  0.8 + 0.2  0.4 ::k 0.2 
0.1 #g A48  BL  4  6.0 3:: 0.6  3.2 + 0.2 
10/,tg A48  BL  7  5.7 ::t=  0.6  2.7 ± 0.7 
Anti-BL and A481d titers were determined 5 d after immunization  with 20 #g 
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of A48 monoclonal protein remaining in the circulation from the original injection of 
10 #g at  birth.  Furthermore, we studied the PFC response of mice treated at  birth 
with various amounts of A48 monoclonal protein and immunized 1 mo later with BL. 
The results depicted in Fig. 3 showed that the magnitude of the total direct anti-BL 
PFC response was not significantly different in the mice whether or not they were 
treated  at  birth.  However,  the  A48  component of this  response  was  significantly 
increased.  The  combined results  regarding the  complete clearance of labeled A48 
protein 1 mo after injection and the possibility of detecting an A48Id  + PFC response 
demonstrate a  genuine activation of A48Id  + clones. It should be mentioned that the 
PFC  results  indicate  that  A48Id  silent  clones  dominate  the  anti-BL  response  in 
animals treated at birth with A48 monoclonal protein. 
Ontogeny of the A48Id Response.  The ontogeny of the A48]d response was studied in 
two groups of animals. The first group was injected at  birth with A48 monoclonal 
protein and immunized either  1,  2,  or 3  wk  later with  BL.  The second group  was LEONARD  RUBINSTEIN,  MING YEH,  AND CONSTANTIN BONA  511 
injected at various intervals after birth with A48 monoclonal protein and immunized 
1 mo later with BL. The results of this experiment, presented  in Table III, showed 
that  1-d-old  A48-pretreated  BALB/c  mice  immunized  2  or  3  wk  later  with  BL 
developed an A48Id  response.  Similar results were obtained by using a  PFC  assay 
(data not shown). In contrast, the animals injected with A48 at various intervals after 
birth (7-28 d) and immunized 1 mo later with BL failed to develop an A48Id response 
despite  a  strong  anti-fl2---*6 fructosan  antibody  response  (data  not  shown).  These 
results show that treatment at birth with A48 monoclonal protein is critical for the 
activation of A48Id component of the anti-BL response. 
Antigenic  Specificity  of Activation  of A48Id  Clones.  The  specificity  of the  antigen- 
dependent  activation of A48Id  component  of the  anti-BL response was studied  in 
animals treated at birth with A48 and immunized  1 mo later with either BL, In-BA, 
or TNP-Ficoll as well as in animals treated at birth with M460 and immunized  1 mo 
later with BL and TNP-Ficoll (Table IV). The animals immunized with BL at  1 mo 
of age have a significant increase in the titer of only anti-B2---~6  fructosan antibodies 
and  of A48Id  component  response compared with  the  mice treated  at  birth  with 
A48Id  monoclonal  protein.  Anti-/82--*6  and  anti-/~2----~l  fructosan  antibody  levels 
were slightly increased in mice immunized with In-BA, however, a significant increase 
of anti-/32---*6 and/~2--> 1, and a  slight increase of A48Id component was observed in 
animals  treated  at  birth  with  A48Id  monoclonal  protein.  These results  show  that, 
despite the ontogenic delay of the anti-~2--~ 1 clones that we previously described (4), 
the administration  at birth of A48 monoclonal protein probably stimulated a  set of 
clones that express at least some A48 idiotopes and that secrete antibody able to bind 
both/~2--~6 and/~2---~ 1 fructosan epitopes. TNP-Ficoll immunization does not affect 
the activation of A48Id  + clones and, conversely, the M460Id component of the anti- 
TNP response was not altered by A48 treatment at birth. Furthermore, treatment at 
birth  with  M460Id  did  not  activate  A48Id  component  of the  anti-BL  response. 
Therefore, our results suggest that the activation of A48Id silent clones is antigen, as 
TABLE III 
Ontogeny of the A 48Id Response 
Antibody response: Anti/~2---6 
Age of mice  fructosan  Idiotype response: A48Id 
BL im-  A48 treat-  Assay of 
muniza-  HA*  RIA:I:  HI§  RIA:~ 
ment  tion  response 
d  d 
Nil  7  12  NDll  <0.1  ND  ND 
l  d  8  12  ND  1.1  =t: 0.1  ND  ND 
Nil  14  19  4.3 ±  0.3  1.6 ±  0.2  0.3 ±  0.3  1.7 ±  0.7 
1 d  14  19  5.7 ±  0.3  1.2 3= 0.8  1.7 ±  0.3  14.2 +  3.3 
Nil  21  26  4.3 +  0.7  1.1  :t: 0.6  0.0  ±  0.0  1.7 ±  0.1 
1 d  21  26  4.7:1:0.3  1.3 ±  0.7  1.0 ±  0.6  0.4 ±  0.1 
Immunization of mice was performed with 20 #g BL intravenously, whereas the treatment at birth was 
carried out with 10 #g A48 monoclonal protein intraperitoneally. 
* Titer recorded is mean 3= SEM of log2 of the highest dilution of antisera giving agglutination. 
Titer recorded is mean ±  SEM for of protein in sera ~g/ml). 
§ Titer recorded is mean ±  SEM of log2 of the highest dilution of sera giving inhibition. 
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well as idiotype, specific. Interestingly, the activation of a set of clones expressing the 
A48Id reactive to both fl2---6 and f12--~l  fructosan epitopes was observed in  these 
animals.  The  existence  of these  clones  was  confirmed  by  analysis  of monoclonal 
antibodies  obtained  by  fusion  of  SP2/0  myeloma  cells  with  spleen  cells  from 
BALB/c  mice  treated  at  birth  with  A48  and  immunized  with  BL.  Among  eight 
monoclonal  antibodies,  we  found  five that  bound  to fl2---6  and  f12--~l  fructosan 
epitopes. (B. Goldberg and C. Bona, manuscript in preparation). 
Effect  of BL-binding  Monoclonal Antibodies Sharing the A48Id.  There  are  data  that 
suggest that the A48Id of A48 myeloma protein is composed of several idiotopes and 
that some of them are shared with UPC 10, another fl2---6 fructosan-binding myeloma 
(16).  Recently,  we  have obtained  four  monoclonal  antibodies  from BALB/c  mice 
producing anti-(anti-A48Id)  antibodies that  were immunized with BL. These anti- 
bodies also express some of the idiotopes of the A48 family, as was assessed by cross- 
adsorption  experiments  of anti-A48Id  antibodies  in  the  ELISA assay.  The  results 
presented  in  Table  V  showed  that  only  a  few  idiotopes  of A48Id  are  shared  by 
UPC10,  76BL(Abs)36,  and  76BL(Abs)42 because:  (a)  the binding of alkaline phos- 
phatase-labeled anti-A48Id antibody to U I 0, 76BL(Abz) 36, and 76BL(Abs) 42 micro- 
titer plates is significantly lower than that of anti,A48 to A48;  (b) the binding of anti- 
A48  antibodies  to microtiter plates coated with  A48  is only partially adsorbed  by 
equal  amounts  of U10  and  76BL(Abz)42;  (c)  the  binding  of  anti-A48  alkaline 
phosphatase-labeled antibody to U 10 and 76BL(Aba)42 was completely adsorbed by 
A48 and only partially by 76BL(Aba)42. These results indicate that some of the A48 
idiotopes are shared by U 10, 76BL(Abs)42, and 76BL(ABs)36 monoclonal antibodies. 
It  should  be  mentioned  that  76BL(Abs)36  monoclonal  antibodies  probably share 
some idiotopes of U10  because the  adsorption  with  U10  completely inhibited  the 
binding of labeled anti-A48  to  76BL(Abs)36-coated  plates,  whereas the  adsorption 
with  A48  caused  only  60%  inhibition  of this  binding.  Based  on  these  resuhs,  we 
investigated the ability of the three monoclonal antibodies that share A48 idiotopes 
to activate A48Id clones. The results presented in Table VI show that treatment at 
birth  with  U10  and  76BL(Abs)42  followed  by immunization  with  BL  1 mo later 
elicited an anti-BL response whose magnitude was comparable with that of normal 
animals. The pretreatment with U10 and  76BL(Abs)42 caused a  discrete activation 
of A48Id clones, whereas the pretreatment with 76BL(Abz)36 did not. This difference 
can be related to the fact that 76BL(Abz)36 monoclonal antibody shares only one or 
TABLE V 
Ability of Three [32--*6 Fructosan-binding Monoclonal Antibodies to Adsorb the Binding Capacity of 
Anti-A48Id Antibodies 
Microtiter plates 
coated with 
Alkaline phosphatase-labeled anti-A48Id antibodies adsorbed with 
Nil  M384  A48  U10  76BL(Aba)36 76BL(Aba)42 
A48  1.85  1.86  0.05  1.15  ND  0.57 
UPC 10  0.55  0.53  0.01  0.12  ND  0.08 
76BL(Abs)36  0.35  0.36  0.11  0.01  0.0  ND 
76BL(Aba)42  0.39  0.38  0.02  0.05  ND  0.01 
Microtiter plates were coated with 50 p.g antibodies. Adsorption of labeled anti-A48Id antibodies (5 #g]ml) 
was performed by preincubation for 30 rain at 23°C with 10 tag of affinity-purified monoclonal proteins. 
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TABLE  VI 
Treatment at Birth with Different Monoclonal Antibodies 
Treatment  Immunization at 1 mo 
at birth 
Antibody response  Idiotype response 
BL  TNP  A48  M460 
Nil  BL  5.0 ±  2.6  <3  <1  0.2 ±  0.2 
Nil  TNP-Ficoll  0.7 ±  0.3  >100  2.5 ±  1.6  0.3 +  0.0 
A48  BL + TNP-Ficoll  37.1 ±  21.7  >100  173.3 +  63.3  1.8 ± 0.8 
U10  BL +  TNP-Ficoll  1.1 :t: 0.4  ND*  12.0 ±  6.4  1.8 ±  0.7 
76-36  BL + TNP-Ficoll  2.0 +  0.8  84.9 ±  39.2  <1  0.3 ± 0.1 
76-42  BL + TNP-Ficoll  3.6 ±  1.8  37.0 ±  17.0  27.7 +  5.0  0.9 ± 0.6 
1-d-old BALB/c mice were injected with  10 #g monoclonal antibodies.  1-mo-old  BALB/c mice were 
injected with 20 #g BL or 20 #g TNP-FicolI. Antibody and idiotype concentrations were determined in 
RIA and expressed as mean +  SEM (#g/ml). 
* Not determined. 
TABLE  VII 
Failure to Transfer A48Id Response with B Cells from  l-too-old Mice Treated at Birth with A48 
Monoclonal Protein 
Lethally irradiated BALB/e mice infused with 
Number  Anti-BL 
PFC/spleen*  of mice  A48Id  ÷ 
studied 
50 ×  I0  s normal B ceils 
50 ×  10  e A48 B cells 
25 ×  10  s normal B cells +  25 X 106 A48 B cells 
% 
1,195 ±  225  2  0 
873 ±  335  4  0 
850 ±  120  2  0 
* Expressed as the mean ±  SEM. 
few  A48  idiotopes  that  are  not  regulatory  idiotopes,  as  was  assessed  by  partial 
inhibition of binding of labeled anti-A48 to  76BL(Ab3)36  and subsequent  absorption 
with A48 monoclonal protein  (Table V). 
The Inability of Purified B  Cells to Transfer the A48Id + Response.  The ability of B  cells 
originating  from  animals  that  were  treated  at  birth  with  A48  to  confer A48  clonal 
dominance on the BL response in naive recipients was studied in transfer experiments. 
Purified  B  cells obtained  from animals  either injected with A48 at  birth  or not were 
prepared as described before (Materials and Methods).  5  ×  107 B  cells obtained  from 
normal  animals,  A48-treated  animals,  or an  equal  mixture  of both,  were  infused  in 
lethally  irradiated  adult  BALB/c  mice  (4-6  mo  old),  which  were  subsequently 
immunized  with  BL.  The  anti-BL  response  was  estimated  by  the  PFC  method  5  d 
after challenge. As can be seen in Table VII, no A48Id response was detected in these 
animals.  These  results  clearly indicate  that  A48 treatment  at  birth  does  not  directly 
stimulate A48Id B  cell precursors,  and that  the B  cells from A48-treated  animals had 
no effect on B  cells from the normal animals. 
Expansion  of A48Id-specific  Helper  T  Cells.  In  further  experiments,  we investigated 
the effect of T  cells from animals treated at birth with A48 on the activation of silent 
clones.  In the  first set  of experiments,  a  mixture  of 5  ×  107  B  cells plus  2.5  ×  107  T 
cells  from  A48-treated  animals  was  infused  into  lethally  irradiated  adult  BALB/c 
mice,  which  were  immunized  with  BL.  An  anti-BL  PFC  response  comparable  in 
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only  the  animals  infused with  B  and  T  cells  together  developed an  anti-BL  PFC 
response, of which 90%  expressed the A48Id  (Table VIII). An A48Id  +  response was 
not obtained  in  animals infused with B  eeUs from A48-treated mice mixed with T 
cells from normal  animals, or T  cells from A48  mice treated with anti-Lyt-l.2 plus 
complement. The  results of this experiment indicated that  the expression of A48Id  + 
BL-speeific clones is  dependent  upon  the presence of Lyt-l.2  +  helper cells that  are 
lacking in the animals not treated at birth with A48. It should be mentioned  that an 
infusion of equal numbers of T  cells from normal animals together with A48-treated 
TABLE  VIII 
Ability  to Transfer A 48Id + Response in Lethally Irradiated BALB/c Mice with Syngeneic T Cells from 
Mice Treated at Birth with A48 Monodonal Protein 
Mixture of cells infused into irradiated BALB/c mice 
T cells 
B cells A48  Treat-  Normal  A48  merit  Treatment 
Anti-BL response 
Total  A48id  + 
PFC/splecn 
% 
Nil  Nil  Nil  10  0 
50 ×  106  Nil  Nil  873 4. 335  0 
50 ×  I0  s  Nil  25 ×  106  Nil  380 4.  10  91 
50 ×  I06  Nil  25 ×  106  Anti-Lyt-l.2 +  C'*  140 4. 60  8 
50 ×  106  25 ×  106  Nil  25 X 10  s  Nil  310 4- 10  91 
50 ×  106  25 ×  10  s  Nil  25 ×  106  Anti-Lyt-l.2 + C'  190 :t= 40  24 
B cells A48 and T  cells A48 originate from l-ms-old BALB/c mice injected at birth with  10 #g A48. 
Lethally irradiated mice after infusion of lymphocytes  were injected intravenously with 20 #g BL and the 
anti-BL PFC response was studied 5 d later. The anti-BL PFC/spleen response is expressed as the mean 
4. SEM. 
* C', complement. 
TABLE  IX 
Demonstration of A48Id-specific Helper T Cells in BALB/c Mice Treated at Birth with 10 #g A48 
Monodonal Protein: Helper Effect on Anti-TNP Antibody Response in Nude Mice 
Number 
Nude BALB/c mice infused  Treatment of T cells  Immunization  of mice  Anti-TNP 
with  with  studied  PFC/spleen 
Nil  Nil  3  492 +  79 
Nil  TNP-Ficoll  2  90,200 4- 24,400 
Nil  TNP-A48  2  275 4- 275 
Nil  TNP-M384  2  378 4- 298 
25 ×  10  s normal T cells  TNP-A48  4  490 4- 437 
25 ×  106 normal T cells  TNP-M384  4  212 4.  116 
25 ×  106 A48 T cells  TNP-A48  7  1,674 4. 653 
25 ×  106 A48 T cells  TNP-M384  2  5 4. 5 
25 ×  106 A48 T cells  Anti-Thy-l.2 +  C'*  TNP-A48  2  50 4. 0 
25 ×  I0  e A48 T cells  Anti-Lyt-l.2 +  C'  TNP-A48  6  524 4- 190 
25 ×  106 A48 T cells  Anti-Lyt-2.2  + C'  TNP-A48  4  935 4. 343 
T cells were purified on nylon wool columns from spleens of l-ms-old BALB/c mice treated at birth with 
10 #g A48 monoclonal protein. The anti-TNP response was studied 7 d after infusion of T lymphocytes 
and immunization with TNP conjugates.  All mice were immunized with 50 #g of the appropriate TNP 
conjugate.  The anti-TNP PFC/spleen response is expressed as the mean 4- SEM. 
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animals did not alter the A48Id response. These results show that the activity of these 
cells was not altered by putative, naturally occurring A48Id-specific suppressor cells 
(5),  at  least  on  a  one-to-one cell  basis  ratio,  as was assessed by the  appearance of 
A48Id  + cells in animals infused with a mixture ofT cells purified from normal as well 
as mice treated with A48 at birth. To study the specificity of these cells, we tried to 
enrich them on petri dishes coated with A48 monoclonal protein.  Because we failed 
to  enrich  for or deplete  whole  splenic  populations  of these  T  cells  by the  plating 
method, we studied  the specificity of these cells in nu/nu BALB/c mice infused with 
T  cells and  immunized with  an  A48-TNP conjugate.  We studied  this  response by 
measuring the anti-TNP PFC response. The rationale of this experiment was that if 
A48-treated  mice  generate  A48Id-specific helper  T  cells,  such  cells  will  provide a 
helper  effect  to  anti-TNP  B  cell  precursors  through  an  A48-TNP  antigen  bridge. 
Indeed, the infusion of purified T  cells from mice treated with A48 at birth enabled 
nu/nu BALB/c  mice immunized  with  A48-TNP,  but  not  with  MOPC384  (M384)- 
TNP conjugates, to mount an anti-TNP response. The helper effect of these T  ceils 
was ablated by treatment with anti-Thy-l.2 and anti-Lyt-l.2 plus complement and 
was  not  altered  by  anti-Lyt-2.2  plus  complement  (Table  IX).  In  another  set  of 
experiments aimed to determine the specificity of helper T  cells, we studied the effects 
of  treatment  of  these  cells  with  A48  monoclonal  protein  and  complement.  The 
rationale of this experiment follows from previous findings in which it was shown that 
murine IgA-antigen complex can activate the complement  (17)  and that its binding 
to cellular antigen can cause the lysis of cells in presence of complement (18).  Kohler 
has succeeded in eliminating the T15Id-specific helper T  cells by treatment with T15 
and complement  (personal  communication).  Therefore, T  cells from BALB/c mice 
injected with  10/zg A48 at birth were incubated for 1 h  at 37°C  with  1 mg A48 or 
M384  proteins and guinea pig complement diluted  1:3.  After washing,  25  ×  106 T 
cells were infused  into  four nude  mice that  were challenged with  50 big TNP-A48 
conjugate. Mice infused with T cells that were pretreated with M384 plus complement 
developed 3,538 4- 512 anti-TNP PFC/spleen, whereas the mice infused with T  cells 
treated  with  A48  plus  complement  showed  a  significant  decrease  in  the  anti-TNP 
PFC response (i.e., 883 4- 478). In this experiment, the control nude mice infused with 
25  ×  106  T  cells  from  normal  mice  and  subsequently  challenged  with  TNP-A48 
developed only 490  anti-TNP  PFC/spleen.  These results confirmed the presence of 
A48Id-specific T  cells in mice treated at birth with A48 monoclonal protein. 
Discussion 
The balance between clones as well as communications which is established between 
various  subsets  of regulatory  T  cells  based  on  fragile  idiotypic  links  can  be easily 
perturbed  by  antigens,  idiotypes,  and  anti-idiotype  antibodies.  In  this  paper,  we 
present new results that show that the administration ofA48Id monoclonal protein at 
birth  has  a  profound  effect on  the  expression  of the  A48Id + anti-/32----)6 fructosan 
precursor of antibody-forming cells.  Neonatal treatment as well as the treatment of 
mice during  the  first  weeks  after birth  with  monoclonal  protein  led  to  the  A48Id 
dominance of the anti-fl2----~6 fructosan antibody response. Once the dominant/32-41 
fructosan reactive clones emerge 28 d  after birth, one can no longer activate A48Id 
clones. Indeed, no A48Id-bearing antibodies were detected in 4-wk-old BALB/c mice 
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Two  groups  of findings  demonstrate  that  this  activation  is  idiotype  as  well  as 
antigen dependent and specific: (a) the administration at birth of M460 monoclonal 
protein led to an increase of M460Id component of anti-TNP antibodies, but not of 
the A48Id component of anti-fl2---~6  fructosan response;  (b)  only the administration 
with  BL of 1-mo-old BALB/c mice  treated  at  birth  with  A48  protein  elicited  an 
A48Id  ÷ BL-specific response, whereas immunization with TNP-Ficoll does not. These 
results are in agreement with those reported by Reth et al.  (19), which showed that 
the increase of (4-hydroxy-3-nitrophenyl)acetyl(NP) Vnbld component after injection 
of NP-binding monoclonal antibodies in adult mice requires specific antigenic stim- 
ulation. A small but significant stimulation of the f12---~ 1 fructosan-reactive clones was 
observed in BALB/c mice that were injected at birth with A48 monoclonal protein 
and challenged 1 mo later with In-Ba. This observation is quite surprising as we have 
previously shown a significant ontogenic delay of the expression of these clones in that 
they only become dominant in 6-wk-old mice (4). However, the premature activation 
of these clones can be exclusively related to a more profound alteration of the steady- 
state balance at birth maintained between the clones by the administration of A48 
monoclonal protein.  We  previously described an  "indirect idiotype phenomenon" 
based on the observation, made  in  nude  mice, that  treatment  with  anti-E109IdX 
antibodies resulted in a long-lasting suppression of anti-fl2----)  1 fructosan response that 
was paralleled by an increase in the total anti-fl2--*6 fructosan response in addition 
to the appearance of A48Id  ÷ antibodies (20).  Preliminary data regarding the analysis 
of antigen-binding specificity of several monoclonal antibodies obtained from mice 
treated at birth with A48 monoclonal protein show that they exhibit a high binding 
activity to fl2---~6 fructosan epitopes, but  they also  bound f12----~  1 fructosan. These 
results would suggest that the products of clones that were activated by manipulation 
of the immune network differ from those activated in adult mice after immunization 
with BL as well as from In-binding myeloma proteins that exhibit a  higher binding 
activity for f12---~  1 fructosan epitopes than for fl2---~6  fructosan epitopes (3). 
The  A48  idiotype  expressed  on  A48  myeloma  protein  is  composed  of several 
idiotopes  (16);  some  of them  are  shared  by  U10  monoclonal  protein  and  fl2----~6 
fructosan-binding monoclonal antibodies that we have recently obtained. The treat- 
ment at birth with U10 and  76BL(Aba)42, but not with  76BL(Aba)36, monoclonal 
antibodies led to the activation of A48Id. These results support our previous concept 
concerning  the  regulatory  idiotype  network  in  that  only  few  idiotopes--that  is, 
regulatory idiotopes--function in an autologous system. We proposed that regulatory 
idiotypes might  be a  feature only of those idiotypes that  are capable of becoming 
dominant idiotypes, possibly because it is these determinants that call for the T  cell 
regulatory responses (2, 7). 
Our results show that the activation of  A48Id silent clones depends on the expansion 
of A48Id-specific helper T  cells. The infusion of B cells from A48-treated mice into 
irradiated mice at birth does not cause the production of A48Id-bearing antibodies in 
response to immunization with  BL. This clearly demonstrated  that  A48Id-bearing 
immunoglobulins  have  no  effect on  B  cells  that  carry  the  A48  immunoglobulin 
receptor. By contrast, the infusion of irradiated animals with a  mixture of T  and B 
cells  from  A48-treated  mice  induced  the  occurrence of A48Id-bearing  antibodies. 
These T  cells express Lyt-l.2 alloantigen and their activity cannot be overcome by 
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ratio. Because we failed to enrich for the putative A48Id-specific helper T  cells on 
A48-coated dishes, we studied  the specificity of the receptor of these cells in  nude 
mice. In these experiments we found that nude mice infused with T  cells from animals 
treated at birth with A48 contained a discrete subset of cells that recognize the A48 
idiotypes. When these cells were infused into nude BALB/c mice, they rendered them 
capable  of mounting  an  anti-TNP  response  upon  immunization  with  A48-TNP 
conjugate. This subset of cells that exert their helper effect through an antigen bridge 
were also sensitive to A48 and anti-Lyt-l.2 antiserum plus complement treatment. It 
is conceivable that the antigen bridge through which these T  cells exert their helper 
effects in A48-treated animals can be composed of bacterial levan-A48Id  + antibody 
complex. A precedent for T  cells that exert their effect through an antigen bridge in 
which the antigen is bound to an immunoglobulin receptor which is simultaneously 
recognized by T  cell receptor were previously described in the MOPC315 system. In 
this system, it was shown that BALB/c splenocytes specific for TNP-modified synge- 
neic cells could induce the lysis of MOPC315  cells in the presence of soluble TNP 
conjugates (21). The possibility remains, however, that they may be distinct from the 
subset of cells observed to help in the expression of A48Id  + BL-specific response in 
lethally irradiated mice. Therefore, our present results suggest that the treatment with 
A48 monoclonal protein at birth activates A48Id-specific helper T  cells that select for 
expansion subsequent antigenic stimulation those clones that express A48Id on their 
immunoglobulin receptors. Attempts to clone these helper T  cells in our laboratory 
will provide information on their fine idiotype specificity, target, and phenotype, as 
well as major histocompatibility complex restriction. 
One may ask whether clonal activation by parenteral administration of idiotype at 
birth has any physiological significance. It is well known that significant amounts of 
IdX-bearing antibodies specific for environmental antigens  can  be detected in  the 
sera of nonimmunized adult mice (22). Furthermore, the precursors responsible for 
mounting these antibody responses can be detected in newborn mice by precursor 
frequency  analysis  (23).  In  addition,  various  investigators  have  observed  that  a 
vigorous immune response for environmental antigens  (e.g., phosphocholine, fl2.-.,6 
fructosan, al---~3 dextran, galactan, arsonate, TNP coupled to TI-1 antigens) can be 
elicited in  1-7-d-old mice (24). Therefore, the passive influx of maternal idiotypes in 
the immune system of the embryo or newborn, by placenta or colostrum transfer, can 
influence the idiotype distribution by favoring the expression of those clones that were 
dominant in the maternal immune system. In the rabbit, Wikler et al.  (25) have also 
shown  that  progeny can learn  to make antibodies bearing the  idiotype of another 
rabbit  by maternal transfer of anti-(anti-Id)  antibodies.  In physiological terms it is 
extremely advantageous to have the immune experience of the mother transmitted to 
the next generation with the resulting expansion of precursors that are specific for a 
response against commonly encountered pathogens prevalent in the species. This is 
particularly important in a given period of the postnatal life when the concentration 
of antibodies  provided from the mother starts  to  decline.  Absence of an  idiotype- 
induced expansion can clearly explain the observation that exposure of the human 
population to new pathogens that had not been encountered in previous generations, 
frequently results in widespread epidemics (e.g., influenza pandemics after a  major 
antigenic shift of the influenza virus hemagglutinins)  (26). 
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immunity as not only a passive acquisition of maternal antibodies, but also a priming 
of the immune system for specific immune responses. This would suggest that once an 
immune response is  initiated  by antigenic stimulation,  the actual  antigen-response 
clones that will proliferate can be determined by the idiotypic repertoire of the mother 
that has been established by an earlier encounter with the same antigen. 
Summary 
BALB/c mice immunized with bacterial levan (BL) produce a  vigorous antibody 
response that fails to include antibodies expressing the idiotype of the fl2---,6 fructosan- 
binding myeloma protein ABPC48 (A48). Treatment of newborn BALB/c mice at  1 
d  of age with 0.1-10 #g of either the A48 myeloma protein or monoclonal proteins 
that share idiotopes with the A48 family, followed by immunization with BL 2-4 wk 
later, produces an anti-BL response that is dominated by the A48Id. Various degrees 
of activation of the A48Id BL response were observed by injecting mice with A48 
monoclonal protein only up  until  3  wk of age.  Activation of the A48Id  clones by 
treating with A48 monoclonal protein was ineffective in mice who were older than 4 
wk. Elicitation of an A48Id BL response required specific antigenic stimulation with 
either fl2---6 or f12--*l  fructosan epitopes, because it does not  occur after injection 
with TNP-Ficoll in  spite of the A48  treatment.  The expansion of A48Id clones in 
mice treated at birth with A48 monoclonal protein is associated with an increase in 
A48Id-specific helper T  cells.  The binding specificity of these cells was demonstrated 
by infusing them into nu/nu BALB/c mice and observing that they rendered help that 
enabled the animal  to mount an anti-TNP response after immunization only with 
A48-TNP, but not with MOPC384-TNP conjugates. The helper activity of these cells 
is sensitive to the effects of treatment with anti-Lyt-l.2 antibodies plus complement. 
A predominantly A48Id BL-specific response can be transferred into lethally irradi- 
ated mice by infusing them with purified T  and B cells from A48-treated mice. The 
transfer of this  response can  be  ablated  by treating  the  T  cells with  anti-Lyt-l.2 
antibodies plus complement. 
These results indicate that A48Id-specific helper cells possess the ability to select 
the A48Id-bearing B cell precursors for expression, thus exerting a fine-tuning effect 
on the idiotypic expression of the anti-BL repertoire. We propose that this idiotype- 
induced idiotype response, which can be, in principal, induced by idiotypes provided 
by the mother, plays an important role in the expansion of precursors of antibody- 
forming cells during embryonic as well as postnatal life. 
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